Banner
targets (2)
for drugs
Identification
Name Quinolinic Acid
Accession Number DB01796 (EXPT02391)
Type small molecule
Groups experimental
Description

A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. [PubChem]

Structure Thumb
Download: MOL | SDF | SMILES | InChI
Display: 2D Structure | 3D Structure
Synonyms Not Available
Brand names Not Available
Brand name mixtures Not Available
Categories Not Available
CAS number 89-00-9
Weight Average: 167.1189
Monoisotopic: 167.021857653
Chemical Formula C7H5NO4
InChI Key InChIKey=GJAWHXHKYYXBSV-UHFFFAOYSA-N
InChI
InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)
Plain Text
IUPAC Name
pyridine-2,3-dicarboxylic acid
SMILES
OC(=O)C1=CC=CN=C1C(O)=O
Plain Text
Mass Spec Not Available
Taxonomy
Kingdom Not Available
Classes Not Available
Substructures Not Available
Pharmacology
Indication Not Available
Pharmacodynamics Not Available
Mechanism of action Not Available
Absorption Not Available
Volume of distribution Not Available
Protein binding Not Available
Metabolism
Route of elimination Not Available
Half life Not Available
Clearance Not Available
Toxicity Not Available
Affected organisms Not Available
Pathways Not Available
Pharmacoeconomics
Manufacturers Not Available
Packagers Not Available
Dosage forms Not Available
Prices Not Available
Patents Not Available
Properties
State solid
Melting point 228.5 oC
Experimental Properties
Property Value Source
water solubility 11 mg/mL at 25 oC [YALKOWSKY,SH & DANNENFELSER,RM (1992)] PhysProp
Predicted Properties
Property Value Source
water solubility 4.07e+00 g/l ALOGPS
logP 0.15 ALOGPS
logP -0.59 ChemAxon Molconvert
logS -1.61 ALOGPS
pKa 3.89 ChemAxon Molconvert
hydrogen acceptor count 5 ChemAxon Molconvert
hydrogen donor count 2 ChemAxon Molconvert
polar surface area 87.49 ChemAxon Molconvert
rotatable bond count 2 ChemAxon Molconvert
refractivity 38.04 ChemAxon Molconvert
polarizability 14.36 ChemAxon Molconvert
References
Synthesis Reference Not Available
General Reference Not Available
External Links
Resource Link
KEGG Compound C03722 Link_out
PubChem Compound 1066 Link_out
PubChem Substance 46505240 Link_out
ChemSpider 1037 Link_out
BindingDB 26115 Link_out
ChEBI 16675 Link_out
ChEMBL 16675 Link_out
HET NTM Link_out
ATC Codes Not Available
AHFS Codes Not Available
PDB Entries
FDA label Not Available
MSDS Not Available
Interactions
Drug Interactions
Drug Interaction
Food Interactions Not Available
Targets

1. Nicotinate-nucleotide pyrophosphorylase [carboxylating]

Pharmacological action: unknown

Nicotinate D-ribonucleotide + diphosphate + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1- diphosphate

Organism class: bacterial
UniProt ID: P30012 Link_out
Gene: nadC
Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report Link_out

References:
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed

2. Nicotinate-nucleotide pyrophosphorylase [carboxylating]

Pharmacological action: unknown

Nicotinate D-ribonucleotide + diphosphate + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1- diphosphate

Organism class: bacterial
UniProt ID: O06594 Link_out
Gene: nadC
Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report Link_out

References:
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed

Comments
Drug created on June 13, 2005 07:24 / Updated on November 10, 2010 13:51

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.